Cargando…

A novel molecular signature for predicting prognosis and immunotherapy response in osteosarcoma based on tumor-infiltrating cell marker genes

BACKGROUND: Tumor infiltrating lymphocytes (TILs), the main component in the tumor microenvironment, play a critical role in the antitumor immune response. Few studies have developed a prognostic model based on TILs in osteosarcoma. METHODS: ScRNA-seq data was obtained from our previous research and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Haijun, Liu, Shangyu, Luo, Xiaoting, Sun, Yu, Li, Xiangde, Luo, Kai, Liao, Shijie, Li, Feicui, Liang, Jiming, Zhan, Xinli, Wei, Qingjun, Liu, Yun, He, Maolin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117669/ https://www.ncbi.nlm.nih.gov/pubmed/37090691 http://dx.doi.org/10.3389/fimmu.2023.1150588

Ejemplares similares

Interaction gene set between osteoclasts and regulatory CD4(+) T cells can accurately predict the prognosis of patients with osteosarcoma
por: Li, Feicui, et al.
Publicado: (2023)

Long non-coding RNA and circular RNA and coding RNA profiling of plasma exosomes of osteosarcoma by RNA seq
por: Liu, Yun, et al.
Publicado: (2023)

STAT3 and its targeting inhibitors in osteosarcoma
por: Liu, Yun, et al.
Publicado: (2020)

High GNG4 predicts adverse prognosis for osteosarcoma: Bioinformatics prediction and experimental verification
por: Jiang, Xiaohong, et al.
Publicado: (2023)

ATG16L1 is a Potential Prognostic Biomarker and Immune Signature for Osteosarcoma: A Study Based on Bulk RNA and Single-Cell RNA-Sequencing
por: Qin, Zhaojie, et al.
Publicado: (2022)

A new model of preoperative systemic inflammatory markers predicting overall survival of osteosarcoma: a multicenter retrospective study
por: Huang, Xianying, et al.
Publicado: (2022)

RNA adenosine modifications related to prognosis and immune infiltration in osteosarcoma
por: Chen, Shijie, et al.
Publicado: (2022)

Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction
por: Xie, Long, et al.
Publicado: (2023)

The mitochondrial energy metabolism pathway-related signature predicts prognosis and indicates immune microenvironment infiltration in osteosarcoma
por: Yang, Sen, et al.
Publicado: (2023)

A glycometabolic gene signature associating with immune infiltration and chemosensitivity and predicting the prognosis of patients with osteosarcoma
por: Wang, Fengyan, et al.
Publicado: (2023)

A cuproptosis-related genes signature associated with prognosis and immune cell infiltration in osteosarcoma
por: Yang, Weiguang, et al.
Publicado: (2022)

A Disulfidptosis-Related Gene Signature Associated with Prognosis and Immune Cell Infiltration in Osteosarcoma
por: Chen, Pengyu, et al.
Publicado: (2023)

Construction of a novel mRNAsi-related risk model for predicting prognosis and immunotherapy response in osteosarcoma
por: Li, Zhe, et al.
Publicado: (2023)

The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma
por: Su, Zexin, et al.
Publicado: (2022)

Identification and Validation of a Potent Multi-miRNA Signature for Prediction of Prognosis of Osteosarcoma Patients
por: Luo, Xinle, et al.
Publicado: (2020)

Significance of the neutrophil-to-lymphocyte ratio in predicting the response to neoadjuvant chemotherapy in extremity osteosarcoma: a multicentre retrospective study
por: Tang, Haijun, et al.
Publicado: (2022)

Exploration and Validation of a Novel Inflammatory Response-Associated Gene Signature to Predict Osteosarcoma Prognosis and Immune Infiltration
por: Fu, Yucheng, et al.
Publicado: (2021)

Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma
por: Yang, Jinpo, et al.
Publicado: (2022)

Characterization of the Tumor Microenvironment in Osteosarcoma Identifies Prognostic- and Immunotherapy-Relevant Gene Signatures
por: Tan, Jianye, et al.
Publicado: (2022)

Immune-infiltrating signature-based classification reveals CD103(+)CD39(+) T cells associate with colorectal cancer prognosis and response to immunotherapy
por: Luo, Yang, et al.
Publicado: (2022)

Construction of a tumor immune infiltration macrophage signature for predicting prognosis and immunotherapy response in liver cancer
por: Huang, Anmin, et al.
Publicado: (2022)

The Heterogeneity of Infiltrating Macrophages in Metastatic Osteosarcoma and Its Correlation with Immunotherapy
por: Wang, Zhanchao, et al.
Publicado: (2021)

Immune Infiltration-Related Signature Predicts Risk Stratification and Immunotherapy Efficacy in Grade II and III Gliomas
por: Luo, Cong, et al.
Publicado: (2021)

Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma
por: Liu, Zhongyue, et al.
Publicado: (2022)

Comprehensive analyses of a tumor-infiltrating lymphocytes-related gene signature regarding the prognosis and immunologic features for immunotherapy in bladder cancer on the basis of WGCNA
por: He, Zexi, et al.
Publicado: (2022)

Diagnosis and treatment of primary hyperparathyroidism with pathological fracture of the limbs: A retrospective observational study
por: Liu, Huijiang, et al.
Publicado: (2022)

Highly expressed ribosomal protein L34 indicates poor prognosis in osteosarcoma and its knockdown suppresses osteosarcoma proliferation probably through translational control
por: Luo, Shuju, et al.
Publicado: (2016)

Polyphyllin VII induces apoptosis and autophagy via mediating H(2)O(2) levels and the JNK pathway in human osteosarcoma U2OS cells
por: Li, Xiangde, et al.
Publicado: (2021)

Development of Personalized Signature Based on the Immune Landscape to Predict the Prognosis of Osteosarcoma and the Response to Immunotherapy and Targeted Therapy
por: Feng, Xiaofei, et al.
Publicado: (2022)

Molecular characterization of cancer-intrinsic immune evasion genes indicates prognosis and tumour microenvironment infiltration in osteosarcoma
por: Zhao, Xiaokun, et al.
Publicado: (2023)

Identification of a Signature for Predicting Prognosis and Immunotherapy Response in Patients with Glioma
por: Zong, Wei-Feng, et al.
Publicado: (2022)

Construction of a transcription factor-miRNA-mRNA interactive network elucidates underlying pathogenesis for osteosarcoma and validation by qRT-PCR
por: Tang, Fuxing, et al.
Publicado: (2022)

The hypoxia-related signature predicts prognosis, pyroptosis and drug sensitivity of osteosarcoma
por: Hu, Lin, et al.
Publicado: (2022)

Immune Cell Infiltration as Signatures for the Diagnosis and Prognosis of Malignant Gynecological Tumors
por: Liu, Qi-Fang, et al.
Publicado: (2021)

Developing a 5-Gene Signature Related to Pyroptosis for Osteosarcoma Patients
por: Li, Zhe, et al.
Publicado: (2022)

Novel Immunotherapies for Osteosarcoma
por: Lu, Yubao, et al.
Publicado: (2022)

Macrophages in Osteosarcoma Immune Microenvironment: Implications for Immunotherapy
por: Luo, Zhong-Wei, et al.
Publicado: (2020)

Leveraging Tumor Microenvironment Infiltration in Pancreatic Cancer to Identify Gene Signatures Related to Prognosis and Immunotherapy Response
por: Yang, Jiabin, et al.
Publicado: (2023)

Development of a Novel Immune Infiltration-Based Gene Signature to Predict Prognosis and Immunotherapy Response of Patients With Cervical Cancer
por: Yu, Sihui, et al.
Publicado: (2021)

T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities
por: Wang, Zhan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1a1tmdb2pgp4vu0tpau6qq5l3v